Nonmedical Prescription Pain Reliever and Alcohol Consumption
Among Cannabis Users
Published in: Drug and Alcohol Dependence, 2016
By Scott P. Novak, Nicholas C. Peiper, Gary A. Zarkin
Keywords: Cannabis, opioids, alcohol, epidemiology
Full citation: Novak, S. P., Peiper, N. C., & Zarkin, G. A. (2016). Nonmedical prescription pain reliever and alcohol consumption among cannabis users. Drug and Alcohol Dependence, 159, 101–108.
- 1 Between 2003 and 2013, how have cannabis, nonmedical prescription pain reliever (NMPR), and alcohol consumption changed among individuals 12 and older in the United States?
- 2 How has dual use of NMPR and cannabis changed from 2003 to 2013?
- 3 What is the evidence for a substitution effect between NMPR and cannabis use?
BACKGROUND: This study examined poly-drug use involving the use of cannabis with nonmedical prescription pain reliever use (NMPR) and alcohol use. METHODS: Computer-assisted survey data from the National Survey on Drug Use and Health were examined. The NSDUH is an annual, cross-sectional survey of non-institutionalized citizens in the United States (ages 12+). Replicate analyses were conducted using the 2013 and 2003 survey waves. RESULTS: Higher levels of cannabis use were consistently associated with more frequent consumption of prescription pain relievers, with findings replicating in both 2013 and 2003. While the prevalence of dual users declined from 2003 (2.5%) to 2013 (2.3%), the average number of days used among dual users increased by an average of 20 days over that period. These changes largely occurred among those aged 35 or older, males, whites, and non-illicit drug users. Past-year marijuana use increased by 16% (10.8-12.6%, p-value < .001) whereas NMPR decreased by 15% (4.9-4.2%, p-value < .001). The largest changes occurred after 2011. Persons using the most cannabis generally had higher levels of alcohol use relative to those using the least amount of cannabis. There was a significant increase in the prevalence of dual use between 2003 (10.2%) and 2013 (11.6%), while the prevalence of past-year alcohol use remained relatively stable. CONCLUSIONS: Clinical efforts and public health interventions should consider the possible co-ingestion of cannabis with NMPR and alcohol, as concomitant use may portend negative health effects in the short and long-term.
- Between 2003 and 2013, the past-year prevalence of cannabis and NMPR use significantly increased, while alcohol use did not significantly change.
- The significant decrease in the prevalence of dual NMPR and cannabis use was offset by significant increases in the frequency of use, as the number of days NMPR was used increased across all levels of cannabis use.
- This study provided evidence for a synergistic effect, not a substitution effect, such that greater use of cannabis is associated with greater use of NMPR and other drugs.